Combination of everolimus, exemestane holds promise against post-menopausal breast ca
Results from a phase III clinical trial have shown that combining two existing cancer drugs to treat post-menopausal women with advanced breast cancer resistant to hormonal therapy significantly improves outcome.
More...
|